4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000047
Chief Medical Officer sold 11,366 shares at an average $14.53 ($165,185)
- Chief Medical Officer acquired 6,348 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2025-04-14 | Option exercise 10b5-1 | +6,348 | $1.08 | $6,856 | 123,052 | D |
| Rodman David Malcom Chief Medical Officer | 2025-04-14 | Sale 10b5-1 | −2,966 | $13.69 | $40,613 | 120,086 | D |
| Rodman David Malcom Chief Medical Officer | 2025-04-14 | Sale 10b5-1 | −8,400 | $14.83 | $124,572 | 111,686 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2025-04-14 | Option exercise · Stock Option 10b5-1 | −6,348 | 107,926 | D | ||
| Open-market sales · 11,366 sh · avg $14.53 · $165,185 | |||||||
Loading xslF345X05/wk-form4_1744763954.xml…